MedPath

Intra-articular Injection in Arthroscopic Management of Temporomandibular Diseases

Not Applicable
Conditions
Temporomandibular Joint Disorders
Registration Number
NCT04936945
Lead Sponsor
Sohag University
Brief Summary

The aim of this study is to evaluate the efficacy of intra-articular injection of platelet rich plasma versus hyaluronic acid following diagnostic arthroscopy in the management of patients suffering from degenerative temporomandibular joint (TMJ).

This is a prospective randomized study of 20 patients with TMJ degenerative joint diseases Wilkes IV, V.

Patients will be divided into two groups; Group A: will be treated with operative arthroscopy plus intra-articular platelet rich plasma.

Group B: will be treated with operative arthroscopy plus intra-articular hyaluronic acid.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
    • All patients with reduced mouth opening and/or painful maximum mouth opening.
  • Joint pain.
  • Patients with radiological evidence of degenerative joint disease.
  • Patients with unsuccessful medical conservative treatment for at least two months.
  • Unilateral or bilateral temporomandibular joint involvement.
  • Wilkes stages IV and V
Exclusion Criteria
    • Patients with bony ankylosis .
  • Patients with advanced resorption of the glenoid fossa.
  • Patients with infection or tumors around joint area
  • Patients unfit for intervention medically.
  • Patients who refused to share in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Maximum Interincisal Opening (MIO) Measurementschange from baseline maximum interincisal mouth opening in millimeters at 6 months postoperative

change in maximum inter-incisal mouth opening will be measured in millimeters between preoperative and postoperative at 1 week,3 weeks, the every month till 6 months

Pain Intensity Measurementschange from preoperative pain intensity according to 100 -point visual analogue scale at 6 months postoperative

A 100 -point visual analogue scale (VAS) for the assessment of pain intensity with 0 as the absence of pain and 100 as the worst pain imaginable With filled standardized charts.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sohag University

🇪🇬

Sohag, Egypt

Sohag University
🇪🇬Sohag, Egypt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.